These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6142850)

  • 21. Effect of treatment with antidepressants and neuroleptics on human leukocyte beta-adrenergic receptors.
    Pandey GN; Janicak PG; Pandey SC; Davis JM
    Psychopharmacol Bull; 1989; 25(2):257-62. PubMed ID: 2574896
    [No Abstract]   [Full Text] [Related]  

  • 22. Caffeine and psychiatric medication interactions: a review.
    Broderick PJ; Benjamin AB; Dennis LW
    J Okla State Med Assoc; 2005 Aug; 98(8):380-4. PubMed ID: 16206866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxic and adverse neurologic effects of neuroleptics].
    Nakayama K; Yakutsu N; Koga M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):532-7. PubMed ID: 10434716
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 25. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 26. [Road safety under psychiatric drug targeting].
    Brunnauer A; Laux G
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):366-77. PubMed ID: 18512188
    [No Abstract]   [Full Text] [Related]  

  • 27. Common CYP450 drug interactions with psychiatric medicines: A brief review for the primary care physician.
    Kutscher EC; Carnahan R
    S D Med; 2006 Jan; 59(1):5-9. PubMed ID: 16610463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hypotension caused by psychopharmacological drugs (author's transl)].
    Hebenstreit G
    Wien Med Wochenschr; 1981 Feb; 131(4):109-12. PubMed ID: 6165144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in the field of drug developments. 13].
    Henkler G; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1980; 35(9):517-39. PubMed ID: 6107937
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of antipsychotic medication in the elderly.
    Maletta GJ
    Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathophysiology, medical management and dental implications of fragile X, Rett, and Prader-Willi syndromes.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):693-702. PubMed ID: 14560873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in the field of drug development. 11].
    Henkler G; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1978 Sep; 33(9):551-67. PubMed ID: 32556
    [No Abstract]   [Full Text] [Related]  

  • 33. I.G. stimulants of the central nervous system.
    Behav Neuropsychiatry; 1975 Apr-1976 Mar; 7(1-12):79-80. PubMed ID: 1235851
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced dementia.
    Lowenthal DT; Nadeau SE
    South Med J; 1991 May; 84(5 Suppl 1):S24-31. PubMed ID: 1674627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychotropic agents may induce de novo nonconvulsive status epilepticus].
    Yoshino A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Feb; 20(1):1-10. PubMed ID: 10890017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing prescription of CNS medications in different elderly populations.
    Craig D; Passmore AP; Fullerton KJ; Beringer TR; Gilmore DH; Crawford VL; McCaffrey PM; Montgomery A
    Pharmacoepidemiol Drug Saf; 2003; 12(5):383-7. PubMed ID: 12899112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
    Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adverse drug effects and interactions. What is the current thinking about the use of St. John's wort?].
    Johne A; Roots I
    Pharm Unserer Zeit; 2003; 32(3):242-6. PubMed ID: 12784545
    [No Abstract]   [Full Text] [Related]  

  • 40. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
    Chen JJ
    Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.